Posts by: Patricia Silva, PhD

Patricia Silva, PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

January 14, 2016January 14, 2016

Crohn’s & Colitis Foundation Says Data Starting to Move into IBD Plexus

News

The Crohn’s & Colitis Foundation of America (CCFA) gave a recent update on its research initiative, the large-scale registry platform called IBD Plexus. IBD News Today participated in the media briefing, which took ... Read more

December 29, 2015December 29, 2015

Clinical Trials Underway into Immunotherapies for Crohn’s Disease and Ulcerative Colitis

News

Qu Biologics Inc. recently provided an update for ongoing clinical trials assessing the company’s lead candidate for inflammatory bowel diseases (IBD), namely ulcerative colitis and Crohn’s disease. The company also announced it ... Read more

December 22, 2015December 28, 2015

Ulcerative Colitis Study Begins Treating 1st Pediatric Patient via Fecal Microbial Transplant

News

Rebiotix Inc., a biotechnology company in Roseville, Minnesota, and McMaster Children’s Hospital, a pediatric academic health sciences center in Ontario, Canada, recently announced that the first patient in the ... Read more

December 19, 2015December 21, 2015

Study Reports that Pregnant Women With Inflammatory Bowel Disease Often Have Nutritional Deficiencies

IBD News, News

New data from researchers at the University of Wisconsin, Madison recently revealed that pregnant women with inflammatory bowel disease (IBD) are more prone to developing deficiencies in nutritional parameters. ... Read more

December 9, 2015September 28, 2016

AbbVie Launches Crohn’s & Colitis Scholarship to Help IBD Students

News

AbbVie recently announced the launch of the company’s Crohn’s & Colitis Scholarship, a set of grants with the goal of providing financial support to outstanding students with inflammatory bowel disease ... Read more

December 8, 2015December 8, 2015

Researchers Prove the Immune System Can Affect Microbiota Evolution

News

A new study by researchers at Instituto Gulbenkian de Ciência (IGC) in Portugal revealed that when the body has its own immune system compromised, as happens in patients with inflammatory bowel ... Read more

December 7, 2015February 19, 2016

Janssen Submits Crohn’s Disease Drug STELARA for Approval in the United States and European Union

Crohn's Disease, News

Janssen Biotech, Inc. and Janssen-Cilag International NV, both part of the Janssen Pharmaceutical Companies of Johnson & Johnson, recently announced the submission of the company’s product STELARA® (ustekinumab), developed ... Read more

November 25, 2015November 25, 2015

AstraZeneca Sells US Rights over Gastroenterological Drug Entocort (Budesonide)

News

AstraZeneca recently announced an agreement with Perrigo Company plc regarding the divestment of rights for Entocort® (budesonide) in the United States. Entocort is a locally-acting glucocorticosteroid considered a first-line therapy indicated ... Read more

November 23, 2015November 23, 2015

Future IBD Therapy May Draw on Gut Protein

News

Researchers at UT Southwestern Medical Center recently published the finding of a pathogen-sensing molecule that plays a key role in the maintenance of a healthy gastrointestinal (GI) system. The ... Read more

November 18, 2015November 18, 2015

Janssen Launches Gut Check Mobile Application to Improve IBD Monitoring

IBD News, News

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies, recently announced the launch of a novel tool called Gut Check™, which is designed to improve disease monitoring in patients suffering ... Read more